Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AMA symposium highlights diabetes, obesity treatment

Summary by Times of India
AMA symposium in Prayagraj highlights GLP-1/GIP-based and weekly injectable therapies for type-2 diabetes and obesity, plus lifestyle advice and side effects.

1 Articles

Times of IndiaTimes of India
Lean Right

AMA symposium highlights diabetes, obesity treatment

AMA symposium in Prayagraj highlights GLP-1/GIP-based and weekly injectable therapies for type-2 diabetes and obesity, plus lifestyle advice and side effects.

·India
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Times of India broke the news in India on Monday, July 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Diabetes icon

Diabetes

Obesity icon

Obesity

GLP-1 icon

GLP-1

Uttar Pradesh icon

Uttar Pradesh

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal